GROUP ONE TRADING, L.P. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,846,940
+296.6%
625,701
+513.6%
0.01%
+400.0%
Q2 2023$717,925
+95.1%
101,978
+69.3%
0.00%
+100.0%
Q1 2023$368,011
-55.9%
60,231
-53.9%
0.00%
-50.0%
Q4 2022$835,013
+33.0%
130,675
+99.4%
0.00%
+100.0%
Q3 2022$628,000
-52.8%
65,538
-45.6%
0.00%
-50.0%
Q2 2022$1,331,000
+7294.4%
120,522
+11153.2%
0.00%
Q1 2022$18,000
-97.1%
1,071
-96.7%
0.00%
-100.0%
Q4 2021$629,000
-84.0%
32,935
-79.4%
0.00%
-75.0%
Q3 2021$3,939,000
+787.2%
159,744
+1038.2%
0.00%
+300.0%
Q1 2021$444,000
-70.8%
14,035
-69.6%
0.00%
-80.0%
Q3 2020$1,518,000
+354.5%
46,117
+238.2%
0.01%
+66.7%
Q2 2019$334,000
+145.6%
13,634
-11.5%
0.00%
+200.0%
Q4 2018$136,000
+51.1%
15,403
+118.6%
0.00%0.0%
Q2 2018$90,000
+8900.0%
7,045
+5674.6%
0.00%
Q3 2017$1,000
-96.8%
122
-97.1%
0.00%
Q2 2017$31,0004,2020.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders